All News SillaJen, Inc.

Equities

A215600

KR7215600008

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
3,650 ^KRW	+1.25%		+2.82%	-39.47%

04-22	OSR Holdings and SillaJen Enter into A Memorandum of Understanding to Collaborate the Development of Innovative Therapeutics and Enter the U.S. Market	CI
03-27	SillaJen, Inc. Submits CSR to the US FDA for REN026 Study in Patients with RCC	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OSR Holdings and SillaJen Enter into A Memorandum of Understanding to Collaborate the Development of Innovative Therapeutics and Enter the U.S. Market	04-22	CI
SillaJen, Inc. Submits CSR to the US FDA for REN026 Study in Patients with RCC	03-27	CI
SillaJen to Raise 129.4 Billion Won via Shares Issuance	03-25	MT
SillaJen, Inc.(KOSDAQ:A215600) added to S&P Global BMI Index	18/09/23	CI
Oncolytic Virus Competitive Landscape Clinical Trials, Growth, and Key Companies \| Companies- Genelux Corporation, Candel Therapeutics, CG Oncolgy, DNAtrix, SillaJen Biotherapeutics	08/06/23	AQ
Basilea announces transition milestone for oncology asset BAL0891 triggering milestone payment of USD 4 million by SillaJen	20/12/22	AQ
Switzerland's Basilea Pharmaceutica Secures $4 Million Milestone Payment for Oncology Asset	19/12/22	MT
SillaJen Resumes Trading on Kosdaq	13/10/22	MT
SillaJen Bags Licensing Right to Basilea Pharmaceutica's Oncology Drug	21/09/22	MT
Kosdaq Delists Biotechnology Company SillaJen	19/01/22	MT
An unknown buyer agreed to acquire a 5.1% stake in NeoImmuneTech, Inc. from SillaJen, Inc. for KRW 10.1 billion.	24/11/21	CI
SillaJen, Inc. announced that it has received KRW 40 billion in funding	30/08/21	CI
SillaJen, Inc. announced that it has received KRW 60 billion in funding from M2N Co.,Ltd	14/07/21	CI
SillaJen, Inc. announced that it expects to receive KRW 40 billion in funding	13/07/21	CI
SillaJen, Inc. announced that it expects to receive KRW 60 billion in funding from M2N Co.,Ltd	30/05/21	CI
M2N Co.,Ltd signed LOI to acquire SillaJen, Inc..	20/04/21	CI
SillaJen, Inc.(KOSDAQ:A215600) dropped from S&P Global BMI Index	21/09/20	CI
SillaJen, Inc.(KOSDAQ:A215600) dropped from FTSE All-World Index	21/09/20	CI
SillaJen, Inc. announced that it has received KRW 20 billion in funding	23/04/20	CI
SillaJen, Inc. announced that it expects to receive KRW 20 billion in funding	22/04/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News SillaJen, Inc.

Equities

A215600

KR7215600008

All News

Filters